{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T04:33:54Z","timestamp":1793162034935,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jocn-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Neuroscience"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jocn.2026.112269","type":"journal-article","created":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T12:22:42Z","timestamp":1788438162000},"page":"112269","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Efficacy and safety of recombinant activated factor VII for spontaneous intracerebral Hemorrhage: a GRADE-assessed meta-analysis of randomized controlled trials using frequentist and Bayesian approaches"],"prefix":"10.1016","volume":"154","author":[{"given":"Mohammed A.","family":"Elbahloul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliaa","family":"Gamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayer H.","family":"Ghaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maia E.","family":"Ragab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed W.","family":"Ainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Mohamed","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed K.","family":"Amen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nawaf W.","family":"Bawazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelrhman Waleed","family":"Kotb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jocn.2026.112269_b0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S1474-4422(09)70340-0","article-title":"Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis","volume":"9","author":"Van Asch","year":"2010","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1016\/j.jocn.2026.112269_b0010","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/S1474-4422(24)00369-7","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021","volume":"23","author":"Feigin","year":"2024","journal-title":"Lancet Neurol"},{"issue":"7","key":"10.1016\/j.jocn.2026.112269_b0015","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1161\/01.STR.24.7.987","article-title":"Volume of intracerebral hemorrhage. a powerful and easy-to-use predictor of 30-day mortality","volume":"24","author":"Broderick","year":"1993","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jocn.2026.112269_b0020","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1212\/01.wnl.0000208408.98482.99","article-title":"Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage","volume":"66","author":"Davis","year":"2006","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.jocn.2026.112269_b0025","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1161\/01.STR.27.10.1783","article-title":"Enlargement of spontaneous intracerebral hemorrhage: incidence and time course","volume":"27","author":"Kazui","year":"1996","journal-title":"Stroke"},{"issue":"8","key":"10.1016\/j.jocn.2026.112269_b0030","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"issue":"20","key":"10.1016\/j.jocn.2026.112269_b0035","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1056\/NEJMoa0707534","article-title":"Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage","volume":"358","author":"Mayer","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jocn.2026.112269_b0040","unstructured":"Mayer SA, Davis SM, Begtrup K, Broderick JP, Diringer MN, Skolnick BE, et al. Subgroup analysis in the fast trial: A subset of intracerebral hemorrhage patients that benefit from recombinant activated factor VII? In: Vol. 39. LIPPINCOTT WILLIAMS & WILKINS 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA; 200p. 528\u2013528."},{"key":"10.1016\/j.jocn.2026.112269_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(26)00097-8","article-title":"Recombinant factor VIIa versus placebo for spontaneous intracerebral haemorrhage within 2 h of symptom onset (FASTEST): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial","author":"Broderick","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.jocn.2026.112269_b0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jocn.2026.112269_b0055","doi-asserted-by":"crossref","unstructured":"Cumpston M, Li T, Page MJ, Chandler J, Welch VA, Higgins JP, et al. Updated guidance for trusted systematic reviews: a new edition of the Cochrane Handbook for Systematic Reviews of Interventions. Cochrane Editorial Unit, editor. Cochrane Database Syst Rev. 2019 Oct 3. doi:10.1002\/14651858.ED000142.","DOI":"10.1002\/14651858.ED000142"},{"issue":"1","key":"10.1016\/j.jocn.2026.112269_b0060","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan-a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"4","key":"10.1016\/j.jocn.2026.112269_b0065","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1136\/bmjebm-2022-112102","article-title":"Using risk of Bias 2 to assess results from randomised controlled trials: guidance from Cochrane","volume":"28","author":"Flemyng","year":"2023","journal-title":"BMJ Evid-Based Med"},{"key":"10.1016\/j.jocn.2026.112269_b0070","article-title":"Introduction to the GRADE tool for rating certainty in evidence and recommendations","volume":"25","author":"Prasad","year":"2024","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.1016\/j.jocn.2026.112269_b0075","series-title":"A language and environment for statistical computing (version 4.4. 1)[computer program]","author":"Core Team R. R","year":"2024"},{"key":"10.1016\/j.jocn.2026.112269_b0080","unstructured":"Chapter 23: Including variants on randomized trials | Cochrane [Internet]. [cited 2026 Aug 12]. Available from: https:\/\/www.cochrane.org\/authors\/handbooks-and-manuals\/handbook\/current\/chapter-23#section-23-3-4."},{"issue":"7414","key":"10.1016\/j.jocn.2026.112269_b0085","first-page":"557","volume":"327","author":"Higgins","year":"2003","journal-title":"Measuring inconsistency in meta-analyses bmj"},{"issue":"122","key":"10.1016\/j.jocn.2026.112269_b0090","article-title":"Should studies with no events in both arms be excluded in evidence synthesis?","volume":"1","author":"Xu","year":"2022","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"10.1016\/j.jocn.2026.112269_b0095","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12874-024-02356-6","article-title":"Meta-analysis accelerator: a comprehensive tool for statistical data conversion in systematic reviews with meta-analysis","volume":"24","author":"Abbas","year":"2024","journal-title":"BMC Med Res Method"},{"issue":"7","key":"10.1016\/j.jocn.2026.112269_b0100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010247","article-title":"Plea for routinely presenting prediction intervals in meta-analysis","volume":"6","author":"IntHout","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/j.jocn.2026.112269_b0105","unstructured":"Examining and Interpreting Doi Plot Asymmetry in Meta\u2010Analyses of Randomized Controlled Trials - Furuya\u2010Kanamori - 2025 - Journal of Evidence-Based Medicine - Wiley Online Library [Internet]. [cited 2026 Aug 12]. Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/jebm.70063."},{"key":"10.1016\/j.jocn.2026.112269_b0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmpb.2022.107303","article-title":"Using the bayesmeta R package for Bayesian random-effects meta-regression","volume":"229","author":"R\u00f6ver","year":"2023","journal-title":"Comput Methods Programs Biomed"},{"issue":"12","key":"10.1016\/j.jocn.2026.112269_b0115","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1001\/jamaneurol.2019.2636","article-title":"Effect of recombinant activated coagulation factor VII on hemorrhage expansion among patients with spot Sign\u2013Positive acute intracerebral hemorrhage: the spotlight and STOP-IT randomized clinical trials","volume":"76","author":"Gladstone","year":"2019","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.jocn.2026.112269_b0120","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1161\/01.STR.0000149628.80251.b8","article-title":"Safety and Feasibility of Recombinant factor VIIa for Acute Intracerebral Hemorrhage","volume":"36","author":"Mayer","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2026.112269_b0125","doi-asserted-by":"crossref","unstructured":"Diringer MN, Skolnick BE, Mayer SA, Steiner T, Davis SM, Brun NC, et al. Thromboembolic Events With Recombinant Activated Factor VII in Spontaneous Intracerebral Hemorrhage. 2009.","DOI":"10.1161\/STROKEAHA.109.561712"},{"issue":"4","key":"10.1016\/j.jocn.2026.112269_b0130","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(12)70038-8","article-title":"Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study","volume":"11","author":"Demchuk","year":"2012","journal-title":"Lancet Neurol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112269_b0135","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1161\/STROKEAHA.121.038475","article-title":"Time course of early hematoma expansion in acute spot-sign positive intracerebral hemorrhage: prespecified analysis of the SPOTLIGHT randomized clinical trial","volume":"54","author":"Al-Ajlan","year":"2023","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2026.112269_b0140","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pneurobio.2013.11.003","article-title":"Inflammation in intracerebral hemorrhage: from mechanisms to clinical translation","volume":"115","author":"Zhou","year":"2014","journal-title":"Prog Neurobiol"},{"issue":"3","key":"10.1016\/j.jocn.2026.112269_b0145","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/STROKEAHA.108.524470","article-title":"Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?","volume":"40","author":"Mayer","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.jocn.2026.112269_b0150","article-title":"Haemostatic therapies for acute spontaneous intracerebral haemorrhage","volume":"4","author":"Salman","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.jocn.2026.112269_b0155","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1177\/23969873251340815","article-title":"European Stroke Organisation (ESO) and European Association of Neurosurgical Societies (EANS) guideline on stroke due to spontaneous intracerebral haemorrhage","volume":"10","author":"Steiner","year":"2025","journal-title":"Eur Stroke J"},{"issue":"7","key":"10.1016\/j.jocn.2026.112269_b0160","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"}],"container-title":["Journal of Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826004200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0967586826004200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:50:40Z","timestamp":1793159440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0967586826004200"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":32,"alternative-id":["S0967586826004200"],"URL":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112269","relation":{},"ISSN":["0967-5868"],"issn-type":[{"value":"0967-5868","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of recombinant activated factor VII for spontaneous intracerebral Hemorrhage: a GRADE-assessed meta-analysis of randomized controlled trials using frequentist and Bayesian approaches","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jocn.2026.112269","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112269"}}